Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes.
D000359:Aftercare / Q000592:standards; D000367:Age Factors; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002985:Clinical Protocols / Q000592:standards*; D003131:Combined Modality Therapy; D003625:Data Collection; D006302:Health Services Research; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000453:epidemiology; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011787:Quality of Health Care; D011829:Radiation Dosage; D012008:Recurrence; D006113:United Kingdom / Q000453:epidemiology; D016526:Workload
D013956:Antithyroid Agents; D007457:Iodine Radioisotopes